Jafari Mandana, Farhadi Faeghe, Baradaran Rahimi Vafa, Rahmanian-Devin Pouria, Askari Nafiseh, Askari Vahid Reza
Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Diabetes Metab Disord. 2025 Jan 25;24(1):57. doi: 10.1007/s40200-025-01561-4. eCollection 2025 Jun.
Lycopene is a tetraterpene compound belonging to carotenoids that are widely present in tomatoes and similar products. It is known as a powerful anti-oxidant and a non-provitamin A carotenoid. Lycopene has been found to effectively improve diabetes mellitus and its complications, such as cardiac complications, disorders caused by oxidative stress, and liver and neurological disorders. Furthermore, free radicals have been shown to disrupt the action of insulin by changing the physical state of the target cell membrane, while carotenoids improve insulin secretion and function in blood sugar regulation by neutralizing free radicals. It, therefore, seems that targeted clinical studies are needed to investigate the therapeutic effect of lycopene against metabolic disorders induced by diabetes. This review aims to summarize information on the sources and potential uses of lycopene and the possible mechanisms involved in the reduction of the above diseases. Its protective effects, in terms of toxicity and safety, are also discussed. The literature sources used in this review were PubMed, Google Scholar, Scopus, and Web of Science databases.
番茄红素是一种属于类胡萝卜素的四萜化合物,广泛存在于番茄及类似产品中。它被誉为一种强大的抗氧化剂和非维生素A类胡萝卜素。已发现番茄红素能有效改善糖尿病及其并发症,如心脏并发症、氧化应激引起的紊乱以及肝脏和神经紊乱。此外,自由基已被证明可通过改变靶细胞膜的物理状态来干扰胰岛素的作用,而类胡萝卜素则通过中和自由基来改善胰岛素分泌及在血糖调节中的功能。因此,似乎需要有针对性的临床研究来调查番茄红素对糖尿病诱发的代谢紊乱的治疗效果。这篇综述旨在总结关于番茄红素的来源、潜在用途以及减少上述疾病可能涉及的机制的信息。还讨论了其在毒性和安全性方面的保护作用。本综述使用的文献来源为PubMed、谷歌学术、Scopus和科学网数据库。